Global Angina Market Research Report 2023

Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest

The global Angina market was valued at US$ 11140 million in 2022 and is anticipated to reach US$ 14180 million by 2029, witnessing a CAGR of 4.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Angina is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Angina is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Angina in Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Angina include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angina.

The Angina market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Angina market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Angina companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Angina Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Beta Blockers

1.2.3 Calcium Antagonists

1.2.4 Anticoagulants

1.2.5 Antiplatelet

1.2.6 Nitrates

1.2.7 ACE Inhibitors

1.2.8 Ranolazine

1.3 Market by Application

1.3.1 Global Angina Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Angina Market Perspective (2018-2029)

2.2 Angina Growth Trends by Region

2.2.1 Global Angina Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Angina Historic Market Size by Region (2018-2023)

2.2.3 Angina Forecasted Market Size by Region (2024-2029)

2.3 Angina Market Dynamics

2.3.1 Angina Industry Trends

2.3.2 Angina Market Drivers

2.3.3 Angina Market Challenges

2.3.4 Angina Market Restraints

3.1 Global Top Angina Players by Revenue

3.1.1 Global Top Angina Players by Revenue (2018-2023)

3.1.2 Global Angina Revenue Market Share by Players (2018-2023)

3.2 Global Angina Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Angina Revenue

3.4 Global Angina Market Concentration Ratio

3.4.1 Global Angina Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Angina Revenue in 2022

3.5 Angina Key Players Head office and Area Served

3.6 Key Players Angina Product Solution and Service

3.7 Date of Enter into Angina Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Angina Historic Market Size by Type (2018-2023)

4.2 Global Angina Forecasted Market Size by Type (2024-2029)

5.1 Global Angina Historic Market Size by Application (2018-2023)

5.2 Global Angina Forecasted Market Size by Application (2024-2029)

6.1 North America Angina Market Size (2018-2029)

6.2 North America Angina Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Angina Market Size by Country (2018-2023)

6.4 North America Angina Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Angina Market Size (2018-2029)

7.2 Europe Angina Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Angina Market Size by Country (2018-2023)

7.4 Europe Angina Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Angina Market Size (2018-2029)

8.2 Asia-Pacific Angina Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Angina Market Size by Region (2018-2023)

8.4 Asia-Pacific Angina Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Angina Market Size (2018-2029)

9.2 Latin America Angina Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Angina Market Size by Country (2018-2023)

9.4 Latin America Angina Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Angina Market Size (2018-2029)

10.2 Middle East & Africa Angina Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Angina Market Size by Country (2018-2023)

10.4 Middle East & Africa Angina Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Angina Introduction

11.1.4 Amgen Revenue in Angina Business (2018-2023)

11.1.5 Amgen Recent Development

11.2 Taxus Cardium Pharmaceuticals

11.2.1 Taxus Cardium Pharmaceuticals Company Detail

11.2.2 Taxus Cardium Pharmaceuticals Business Overview

11.2.3 Taxus Cardium Pharmaceuticals Angina Introduction

11.2.4 Taxus Cardium Pharmaceuticals Revenue in Angina Business (2018-2023)

11.2.5 Taxus Cardium Pharmaceuticals Recent Development

11.3 LegoChem Biosciences

11.3.1 LegoChem Biosciences Company Detail

11.3.2 LegoChem Biosciences Business Overview

11.3.3 LegoChem Biosciences Angina Introduction

11.3.4 LegoChem Biosciences Revenue in Angina Business (2018-2023)

11.3.5 LegoChem Biosciences Recent Development

11.4 Lee’s Pharmaceutical

11.4.1 Lee’s Pharmaceutical Company Detail

11.4.2 Lee’s Pharmaceutical Business Overview

11.4.3 Lee’s Pharmaceutical Angina Introduction

11.4.4 Lee’s Pharmaceutical Revenue in Angina Business (2018-2023)

11.4.5 Lee’s Pharmaceutical Recent Development

11.5 Milestone Pharmaceuticals

11.5.1 Milestone Pharmaceuticals Company Detail

11.5.2 Milestone Pharmaceuticals Business Overview

11.5.3 Milestone Pharmaceuticals Angina Introduction

11.5.4 Milestone Pharmaceuticals Revenue in Angina Business (2018-2023)

11.5.5 Milestone Pharmaceuticals Recent Development

11.6 Juventas Therapeutics

11.6.1 Juventas Therapeutics Company Detail

11.6.2 Juventas Therapeutics Business Overview

11.6.3 Juventas Therapeutics Angina Introduction

11.6.4 Juventas Therapeutics Revenue in Angina Business (2018-2023)

11.6.5 Juventas Therapeutics Recent Development

11.7 ViroMed

11.7.1 ViroMed Company Detail

11.7.2 ViroMed Business Overview

11.7.3 ViroMed Angina Introduction

11.7.4 ViroMed Revenue in Angina Business (2018-2023)

11.7.5 ViroMed Recent Development

11.8 Kuhnil Pharmaceutical

11.8.1 Kuhnil Pharmaceutical Company Detail

11.8.2 Kuhnil Pharmaceutical Business Overview

11.8.3 Kuhnil Pharmaceutical Angina Introduction

11.8.4 Kuhnil Pharmaceutical Revenue in Angina Business (2018-2023)

11.8.5 Kuhnil Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Angina Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Beta Blockers

    Table 3. Key Players of Calcium Antagonists

    Table 4. Key Players of Anticoagulants

    Table 5. Key Players of Antiplatelet

    Table 6. Key Players of Nitrates

    Table 7. Key Players of ACE Inhibitors

    Table 8. Key Players of Ranolazine

    Table 9. Global Angina Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Angina Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Angina Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global Angina Market Share by Region (2018-2023)

    Table 13. Global Angina Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global Angina Market Share by Region (2024-2029)

    Table 15. Angina Market Trends

    Table 16. Angina Market Drivers

    Table 17. Angina Market Challenges

    Table 18. Angina Market Restraints

    Table 19. Global Angina Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global Angina Market Share by Players (2018-2023)

    Table 21. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2022)

    Table 22. Ranking of Global Top Angina Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by Angina Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players Angina Product Solution and Service

    Table 26. Date of Enter into Angina Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Angina Market Size by Type (2018-2023) & (US$ Million)

    Table 29. Global Angina Revenue Market Share by Type (2018-2023)

    Table 30. Global Angina Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 31. Global Angina Revenue Market Share by Type (2024-2029)

    Table 32. Global Angina Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global Angina Revenue Market Share by Application (2018-2023)

    Table 34. Global Angina Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global Angina Revenue Market Share by Application (2024-2029)

    Table 36. North America Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America Angina Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America Angina Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe Angina Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe Angina Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific Angina Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific Angina Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific Angina Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America Angina Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America Angina Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa Angina Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa Angina Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa Angina Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Amgen Company Detail

    Table 52. Amgen Business Overview

    Table 53. Amgen Angina Product

    Table 54. Amgen Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 55. Amgen Recent Development

    Table 56. Taxus Cardium Pharmaceuticals Company Detail

    Table 57. Taxus Cardium Pharmaceuticals Business Overview

    Table 58. Taxus Cardium Pharmaceuticals Angina Product

    Table 59. Taxus Cardium Pharmaceuticals Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 60. Taxus Cardium Pharmaceuticals Recent Development

    Table 61. LegoChem Biosciences Company Detail

    Table 62. LegoChem Biosciences Business Overview

    Table 63. LegoChem Biosciences Angina Product

    Table 64. LegoChem Biosciences Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 65. LegoChem Biosciences Recent Development

    Table 66. Lee’s Pharmaceutical Company Detail

    Table 67. Lee’s Pharmaceutical Business Overview

    Table 68. Lee’s Pharmaceutical Angina Product

    Table 69. Lee’s Pharmaceutical Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 70. Lee’s Pharmaceutical Recent Development

    Table 71. Milestone Pharmaceuticals Company Detail

    Table 72. Milestone Pharmaceuticals Business Overview

    Table 73. Milestone Pharmaceuticals Angina Product

    Table 74. Milestone Pharmaceuticals Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 75. Milestone Pharmaceuticals Recent Development

    Table 76. Juventas Therapeutics Company Detail

    Table 77. Juventas Therapeutics Business Overview

    Table 78. Juventas Therapeutics Angina Product

    Table 79. Juventas Therapeutics Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 80. Juventas Therapeutics Recent Development

    Table 81. ViroMed Company Detail

    Table 82. ViroMed Business Overview

    Table 83. ViroMed Angina Product

    Table 84. ViroMed Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 85. ViroMed Recent Development

    Table 86. Kuhnil Pharmaceutical Company Detail

    Table 87. Kuhnil Pharmaceutical Business Overview

    Table 88. Kuhnil Pharmaceutical Angina Product

    Table 89. Kuhnil Pharmaceutical Revenue in Angina Business (2018-2023) & (US$ Million)

    Table 90. Kuhnil Pharmaceutical Recent Development

    Table 91. Research Programs/Design for This Report

    Table 92. Key Data Information from Secondary Sources

    Table 93. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Angina Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Angina Market Share by Type: 2022 VS 2029

    Figure 3. Beta Blockers Features

    Figure 4. Calcium Antagonists Features

    Figure 5. Anticoagulants Features

    Figure 6. Antiplatelet Features

    Figure 7. Nitrates Features

    Figure 8. ACE Inhibitors Features

    Figure 9. Ranolazine Features

    Figure 10. Global Angina Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Angina Market Share by Application: 2022 VS 2029

    Figure 12. Clinics Case Studies

    Figure 13. Hospitals Case Studies

    Figure 14. Other Case Studies

    Figure 15. Angina Report Years Considered

    Figure 16. Global Angina Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Angina Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Angina Market Share by Region: 2022 VS 2029

    Figure 19. Global Angina Market Share by Players in 2022

    Figure 20. Global Top Angina Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angina as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Angina Revenue in 2022

    Figure 22. North America Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Angina Market Share by Country (2018-2029)

    Figure 24. United States Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Angina Market Share by Country (2018-2029)

    Figure 28. Germany Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Angina Market Share by Region (2018-2029)

    Figure 36. China Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Angina Market Share by Country (2018-2029)

    Figure 44. Mexico Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Angina Market Share by Country (2018-2029)

    Figure 48. Turkey Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Angina Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Amgen Revenue Growth Rate in Angina Business (2018-2023)

    Figure 51. Taxus Cardium Pharmaceuticals Revenue Growth Rate in Angina Business (2018-2023)

    Figure 52. LegoChem Biosciences Revenue Growth Rate in Angina Business (2018-2023)

    Figure 53. Lee’s Pharmaceutical Revenue Growth Rate in Angina Business (2018-2023)

    Figure 54. Milestone Pharmaceuticals Revenue Growth Rate in Angina Business (2018-2023)

    Figure 55. Juventas Therapeutics Revenue Growth Rate in Angina Business (2018-2023)

    Figure 56. ViroMed Revenue Growth Rate in Angina Business (2018-2023)

    Figure 57. Kuhnil Pharmaceutical Revenue Growth Rate in Angina Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed